Sallie Life U Feasibility Study (SLU)

February 10, 2025 updated by: Life University

Assessing the Feasibility of a Patient-Driven Chiropractic Patient Portal (SallieTM Life U) for Research Purposes

This feasibility trial explored the usability of the patient-driven chiropractic patient portal, Sallie™ Life U. The study aimed to recruit 30 participants to track their daily symptoms, triggers, and habits over 30 days while completing three questionnaires about their experience with the portal. The first questionnaire was administered after participants created their accounts, the second at the midpoint of tracking (day 15), and the third upon completing the tracking period (day 30). All participation in the study was conducted remotely using the participants' personal devices.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

28

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Georgia
      • Marietta, Georgia, United States, 30060
        • Dr. Sid E Williams Center for Chiropractic Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

No specific population

Description

Inclusion Criteria:

  • Have daily access to technology (smartphone, tablet, or computer)
  • Currently receiving chiropractic care (for the purposes of this feasibility study, this requires at least one chiropractic adjustment each month)

Exclusion Criteria:

- Given software restrictions, participants must also be able to read and write in English and not be visually impaired.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy
Healthy subjects
Testing of Sallie (TM) Life U platform

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant Recruitment
Time Frame: 30 days
Average # of participants to create a SallieTM Life U account per month
30 days
Participant Adherence - Weekly
Time Frame: 30 days
% of participants with daily data input throughout the week
30 days
Participant Adherence - Monthly
Time Frame: 30 days
% of participants with total number of daily data input throughout the month.
30 days
Participant Retention
Time Frame: 30 days
% of participants completing all questionnaires
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Personalized Tracking Metrics (PTMs)
Time Frame: 30 days
Self-generated habits or personal goals that participants create and track in their portals
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Study Director: Stephanie Sullivan, DC, PhD, Dr. Sid E Williams Center for Chiropractic Research

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2024

Primary Completion (Actual)

January 30, 2025

Study Completion (Estimated)

May 1, 2025

Study Registration Dates

First Submitted

January 31, 2025

First Submitted That Met QC Criteria

January 31, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 10, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • I-0031

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Sallie (TM) Life U

Subscribe